Abattis Bioceuticals Corp. (ATTBF)

Abattis Bioceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Fiscal Year	Current	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Feb 17, 2026	Sep 30, 2019	Sep 30, 2018	Sep 30, 2017	Sep 30, 2016	Sep 30, 2015
Market Capitalization	0	9	57	25	6	3
Market Cap Growth	0%	-85.01%	128.88%	345.34%	88.55%	-86.22%
Enterprise Value	-	6	53	24	5	3
Last Close Price	0.00	0.02	0.14	0.16	0.05	0.04
PS Ratio	0.00	31.96	8874.24	-	-	43.57
PB Ratio	0.00	1.07	6.70	40.68	35.28	8.40
P/TBV Ratio	-	-	6.47	20.58	-	-
P/FCF Ratio	0.00	1.22	-	-	-	-
P/OCF Ratio	0.00	1.21	-	-	-	-
EV/Sales Ratio	-	21.23	8180.14	-	-	45.38
EV/FCF Ratio	-	0.81	-	-	-	-
Debt / Equity Ratio	0.01	0.01	-	-	0.15	-
Debt / FCF Ratio	0.02	0.02	-	-	-	-
Net Debt / Equity Ratio	-0.21	-0.21	-0.82	-0.68	-0.04	-0.53
Net Debt / EBITDA Ratio	0.59	0.59	0.58	0.10	0.00	0.09
Net Debt / FCF Ratio	-0.24	-0.24	1.07	0.32	0.01	0.14
Asset Turnover	0.02	0.02	0.00	-	-	0.02
Inventory Turnover	0.78	0.78	-	-	-	-
Quick Ratio	0.53	0.53	31.88	1.49	0.08	0.26
Current Ratio	0.73	0.73	34.51	1.55	0.09	0.31
Return on Equity (ROE)	-28.13%	-28.13%	-1308.59%	-1436.92%	-702.79%	-217.73%
Return on Assets (ROA)	-15.94%	-15.94%	-156.39%	-273.78%	-98.12%	-49.88%
Return on Capital Employed (ROCE)	-27.30%	-27.30%	-142.20%	-703.60%	-939.60%	-629.20%
Earnings Yield	-482744.75%	-26.67%	-105.02%	-24.33%	-31.61%	-111.65%
FCF Yield	1483982.56%	81.98%	-11.46%	-5.26%	-10.52%	-46.40%
Buyback Yield / Dilution	-45.83%	-45.83%	-117.02%	-56.50%	-38.04%	-41.01%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.